AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 MAY 30 - (NewsRx.com & NewsRx.net) -- The College of American Pathologists (CAP) applauds the announcement of new consensus guidelines for the management of abnormal Pap tests. As a participant of last year's consensus conference, when the guidelines were drafted, the college recognizes the importance of clarifying for patients, clinicians, and laboratory professionals appropriate follow-up for women with abnormal, but inconclusive results.
According to the new guidelines, these women should now be tested for the human papillomavirus (HPV), a known precursor for cervical cancer. HPV testing is viewed by experts as more decisive than the previously recommended follow-up Pap tests and colposcopy procedure, and if the woman received a liquid-based Pap test, may not require a return visit for the test.
"Prior to the introduction of these guidelines there was no national consensus on follow-up for women with inconclusive or ASCUS Pap tests," said Dina Mody, MD, FCAP, chair of the College's Cytopathology Committee. "These guidelines help ensure that women throughout the country will receive appropriate care."
The CAP remains steadfast in its belief that, in general, all women who are or have been sexually active, or have reached the age of 18, should have an annual Pap test and pelvic examination.
No cancer screening test ...
Source: HighBeam Research, College of American Pathologists applauds new Pap test guidelines.